Drug Screen (Nonforensic), Urine, Qualitative

0090500
copy
 

Copy Utility


emailprint
Example Reports
Negative
Positive
Ordering Recommendation

Useful in situations where identity or class of the drug or drugs of interest is not known. Not recommended for assessment in routine compliance and/or abuse contexts.

Mnemonic
URN SCREEN
Methodology

Qualitative Immunoassay/Gas Chromatography-Mass Spectrometry/Liquid Chromatography-Tandem Mass Spectrometry

Performed

Sun, Tue-Sat

Reported

1-6 days

New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
Collect

Fresh random urine.

Specimen Preparation

Transport 25 mL urine. (Min: 12 mL)

Storage/Transport Temperature

Refrigerated.

Unacceptable Conditions

Post-Mortem

Remarks
Stability

Ambient: 5 days; Refrigerated: 2 weeks; Frozen: 2 months

Reference Interval
Interpretive Data

The following drugs or drug classes may be detected:

Acetaminophen, barbiturates, benzodiazepines, carbamazepine, carisoprodol, chlorpheniramine, cocaine and metabolites, diphenhydramine, ethchlorvynol, ibuprofen, lidocaine, meprobamate, narcotics and synthetics, phencyclidine, phenothiazines, phenytoin, primidone and metabolites, pyrilamine, salicylate, sympathomimetic amines, theophylline, tricyclic and other antidepressants.

Compliance Statement B: For laboratory developed tests not using a RUO kit, and for FDA approved, cleared or 510(k) exempt assays with alterations. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.

Note

This test is not optimized for most drugs of abuse (amphet/methamphet, barbiturates, benzodiazepines, cocaine, methadone, opiates, propoxyphene, PCP, THC); instead refer to Drug Panel 9, Urine - Screen with Reflex to Confirmation/Quantitation (ARUP test code 0092186), Drug Panel 7, Urine - Screen with Reflex to Confirmation/Quantitation (ARUP test code 0092184).

Hotline History

View Hotline History

 

Hotline History

Date of Change
Test Name Change
Methodology
Performance/Reported Schedule
Specimen Requirements
Reference Interval
Interpretive Data
Note
CPT Code
Component Change
Other Interface Change
New Test
Inactive
02/19/2019
X
X
N/A
CPT Codes

80307

Are you an ARUP Client? Click here for your pricing.
Components
Component Test Code* Component Chart Name LOINC
0090500 Drug Screen (Nonforensic), Urine, Qual 12286-1
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Carisoprodol Screen with Reflex Confirmation
  • Drug Analysis
  • Multiple Drug Analysis
  • Tox Screen Urine
  • Urine Drug Screen
Drug Screen (Nonforensic), Urine, Qualitative